Fig. 4: High vigilance stage A1 as an indicator of treatment responders.

A Prior to treatment, responders had a significantly higher amount of stage A1 compared to non-responders. The effect was found in both ketamine and placebo interventions (B). C Meta-analysis of pretreatment vigilance stage A1 between treatment responders and non-responders to ketamine.